Temasek Capital files 13F Notice for Q3 2026
Temasek Capital (Private) Ltd submits a 13F Notice, highlighting its investment activities as of September 30, 2026, significant for the asset management sector.
Tembusu Capital files latest 13F Notice on portfolio updates
Tembusu Capital Pte. Ltd. files a 13F Notice, indicating updates in investment strategies that may impact the investment management industry.
Temasek Life Sciences files 13F notice, signals strategy change
Temasek Life Sciences Private Ltd files a 13F notice with the SEC, indicating a shift in its investment strategy, impacting the biotechnology sector.
DoubleDown Interactive to Report Q3 Results on November 11
DoubleDown Interactive announces third-quarter financial results release date and conference call details for November 11, 2026.
NovaBridge Biosciences Appoints Chuck Silberstein as CFO
NovaBridge Biosciences names Chuck Silberstein as Chief Financial Officer, effective November 2, 2026, as it advances its clinical programs.
GoldMining Starts Pre-Feasibility Study at Sâo Jorge Project
GoldMining Inc. has begun a Pre-Feasibility Study at its Sâo Jorge Gold Project in Brazil, aiming to enhance resource confidence and optimize mining operations.
Masco Corp reports Q3 2026 results with key financial updates
Masco Corp's Q3 2026 10-Q filing reveals financial updates and performance insights in the heating equipment and plumbing fixtures industry.
Quhuo Ltd secures RMB 10 million credit facility agreement
Quhuo Ltd has entered a credit facility agreement with Xiamen Bank for up to RMB 10 million, enhancing its operational capacity in the business services sector.
Garmin reports strong Q3 results, highlights growth potential
Garmin Ltd's Q3 results show strong performance in navigation and guidance systems, impacting the search and detection industry.
Urban Edge Properties Reports Strong Q3 Results, Revenue Growth
Urban Edge Properties LP reports strong rental revenue growth in Q3 2026, signaling positive trends in the real estate sector amid economic fluctuations.
Oatly Reports Strong Q3 2026 Results Amid Inflation Pressures
Oatly Group AB announces strong Q3 2026 results, highlighting revenue growth and new product launches despite inflation challenges in the food and beverage industry.
DANA Inc reports strong Q3 results, boosts share repurchases
DANA Inc announces strong third-quarter results with increased sales and share repurchases as it prepares for the Eaton Mobility transaction.
Oatly Group AB Reports Third Quarter Financial Results
Oatly Group AB shares key financial updates for Q3 2026, focusing on growth strategies in the competitive food and kindred products industry.
OneSpaWorld Holdings Reports Financial Results for Q3 2026
OneSpaWorld Holdings Ltd announces its Q3 2026 financial results, highlighting operational changes and industry trends in the membership sports and recreation sector.
Stepan Co. reports strong Q3 results amid industry shifts
Stepan Co. announces its Q3 financial results, showcasing resilience in the soap and detergent industry amid evolving market conditions.
Shenandoah Telecommunications reports Q3 2026 results
Shenandoah Telecommunications Company announces its third quarter 2026 financial results, revealing revenue growth and ongoing losses amid fiber expansion.
Garmin Ltd. Announces Q3 2026 Financial Results
Garmin Ltd. reveals its Q3 2026 financial results, shedding light on its performance and future strategies in the navigation and aeronautical systems sector.
Range Resources announces Q3 2026 results in SEC filing
Range Resources Corp reveals its Q3 2026 results, highlighting performance in the crude petroleum and natural gas sector, impacting stakeholders and competitors.
Masco Corporation reports strong Q3 results with sales up 3%
Masco Corporation's third-quarter results show a 3% sales increase and a commitment to shareholder returns, highlighting resilience in the heating and plumbing sector.
Genprex to Present Research at GSA Annual Scientific Meeting
Genprex, Inc. will showcase its research on TUSC2 and REQORSA at the GSA Annual Scientific Meeting, indicating potential therapeutic advancements.